52 assets in Angioimmunoblastic T-Cell Lymphoma

Therapeutic assets addressing Angioimmunoblastic T-Cell Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dexasone Angioimmunoblastic T-Cell Lymphoma	Ou Bai, MD/PHD	P2	BB (71)
Adriamycin Angioimmunoblastic T-Cell Lymphoma	City of Hope Medical Center	P4	BB (70)
Azacitidine Angioimmunoblastic T-Cell Lymphoma	National Cancer Institute (NCI)	P4	BB (70)
Etoposide Angioimmunoblastic T-Cell Lymphoma	Eric Jacobsen, MD	P4	BB (70)
Fludarabine Angioimmunoblastic T-Cell Lymphoma	National Cancer Institute (NCI)	P2	BB (70)
Prednisone Angioimmunoblastic T-Cell Lymphoma	Shanghai Jiao Tong University School of Medicine	P4	BB (70)
Romidepsin Angioimmunoblastic T-Cell Lymphoma	The Lymphoma Academic Research Organisation	P3	BB (70)
Cyclophosphamide Angioimmunoblastic T-Cell Lymphoma	Shanghai Jiao Tong University School of Medicine	P4	BB (69)
(+)-Vincristine Angioimmunoblastic T-Cell Lymphoma	Shanghai Jiao Tong University School of Medicine	P4	BB (69)
Cediranib Angioimmunoblastic T-Cell Lymphoma	National Cancer Institute (NCI)	P2	BB (68)
Rituximab Angioimmunoblastic T-Cell Lymphoma	Ou Bai, MD/PHD	P2	BB (68)
Pralatrexate Angioimmunoblastic T-Cell Lymphoma	Corvus Pharmaceuticals, Inc.	P3	BB (66)
Nivestim Angioimmunoblastic T-Cell Lymphoma	City of Hope Medical Center	P3	B (63)
Dasatinib Angioimmunoblastic T-Cell Lymphoma	Zhengzhou University	P4	B (62)
Brentuximab Vedotin Angioimmunoblastic T-Cell Lymphoma	Northwestern University	P2	B (61)
Cis-Diamminedichloroplatinum Ii Angioimmunoblastic T-Cell Lymphoma	Ou Bai, MD/PHD	P2	B (61)
Mitoxantrone Angioimmunoblastic T-Cell Lymphoma	The Affiliated Hospital of Xuzhou Medical University	P2	B (60)
Nivolumab Angioimmunoblastic T-Cell Lymphoma	Mayo Clinic	P2	B (60)
Pembrolizumab Angioimmunoblastic T-Cell Lymphoma	AstraZeneca	P2	B (60)
Belinostat Angioimmunoblastic T-Cell Lymphoma	Corvus Pharmaceuticals, Inc.	P3	B (58)
Melphalan Angioimmunoblastic T-Cell Lymphoma	Eric Jacobsen, MD	P2	B (57)
Oxaliplatin Angioimmunoblastic T-Cell Lymphoma	Arvinas Inc.	P2	B (57)
Soquelitinib Angioimmunoblastic T-Cell Lymphoma	Corvus Pharmaceuticals, Inc.	P3	B (57)
Tislelizumab Angioimmunoblastic T-Cell Lymphoma	The Affiliated Hospital of Xuzhou Medical University	P2	B (57)
Aclarubicin Angioimmunoblastic T-Cell Lymphoma	Shanghai Jiao Tong University School of Medicine	P2	CCC (53)
Camustine Angioimmunoblastic T-Cell Lymphoma	Eric Jacobsen, MD	P2	CCC (53)
Cytarabine Angioimmunoblastic T-Cell Lymphoma	Eric Jacobsen, MD	P2	CCC (53)
Linperlisib Angioimmunoblastic T-Cell Lymphoma	Peking University	P2	CCC (53)
Tazemetostat Angioimmunoblastic T-Cell Lymphoma	Eric Jacobsen, MD	P2	CCC (53)
Tucidinostat Angioimmunoblastic T-Cell Lymphoma	The Affiliated Hospital of Xuzhou Medical University	P2	CCC (53)
Duvelisib Angioimmunoblastic T-Cell Lymphoma	Alliance for Clinical Trials in Oncology	P2	CCC (51)
azd3470 Angioimmunoblastic T-Cell Lymphoma	AstraZeneca	P1/2	CCC (48)
Gnc-038 Angioimmunoblastic T-Cell Lymphoma	Sichuan Baili Pharmaceutical Co., Ltd.	P1/2	CCC (48)
Anti-Cd7 Car-T Cells Angioimmunoblastic T-Cell Lymphoma	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	P1	CC (44)
Anti-Icos Monoclonal Antibody Medi-570 Angioimmunoblastic T-Cell Lymphoma	National Cancer Institute (NCI)	P1	CC (43)
Arv-393 Angioimmunoblastic T-Cell Lymphoma	Arvinas Inc.	P1	CC (43)
Fludeoxyglucose Angioimmunoblastic T-Cell Lymphoma	City of Hope Medical Center	P1	CC (43)
Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,461-Alanine,462-Alanine,556-Glycine,581-Cysteine,593-Tryptophan), Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 Vh-Ch1 Fragment) Fusion Protein With Peptide (Synthetic 10-Amino Acid Linker) Fusion Protein With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Heavy Chain Vl(.Lambda.)-Ch1-Ch2-Ch3), (222->219''')-Disulfide With Immunoglobulin Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)) And (447->232'')-Disulfide With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Light Chain Vh-Cl(.Kappa.)), (453->228'), (456->231'), (581->351')-Tris(Disulfide) With Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,236-Alanine,237-Alanine,331-Glycine,351-Cysteine,368-Serine,370-Alanine,409-Valine) Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine) Angioimmunoblastic T-Cell Lymphoma	Arvinas Inc.	P1	CC (43)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer Angioimmunoblastic T-Cell Lymphoma	Mayo Clinic	P1	CC (43)
Pegfilgrastim Angioimmunoblastic T-Cell Lymphoma	City of Hope Medical Center	P1	CC (43)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta Angioimmunoblastic T-Cell Lymphoma	Mayo Clinic	P1	CC (43)
Ruxolitinib Angioimmunoblastic T-Cell Lymphoma	Mayo Clinic	P1	CC (43)
Ruxolitinib Phosphate Angioimmunoblastic T-Cell Lymphoma	City of Hope Medical Center	P1	CC (43)
Abatacept Recombinant Angioimmunoblastic T-Cell Lymphoma	National Cancer Institute (NCI)	P1	CC (41)
Autologous Ccr4 Car T Cells Angioimmunoblastic T-Cell Lymphoma	National Cancer Institute (NCI)	P1	CC (41)
Fenretinide Angioimmunoblastic T-Cell Lymphoma	SciTech Development, Inc.	P1	CC (41)
Wu-Cart-007 Angioimmunoblastic T-Cell Lymphoma	Washington University School of Medicine	P1	CC (41)
Anti Cd30 Car-T Cell Angioimmunoblastic T-Cell Lymphoma	Zhejiang University	Early P1	C (38)

Showing 1 to 50 of 52 assets

PreviousPage 1 of 2Next